Product Name: BDC2.5 mimotope 1040-55, mouse
Product Number: PE-01AMV95
Size: | 200 µg | | Price: | 32.00 |
| 1 mg | | $US | 64.00 |
Peptide Name: BDC2.5 mimotope 1040-55, mouse
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Mus musculus
Peptide Sequence: RVRPLWVRME
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: Amide
Peptide Molecular Mass Calculated: 1340.62 Da
Peptide Purity Percent after Synthesis and Purification: >95
Peptide Appearance: White powder
Peptide Form: Solid
Storage Conditions: -20°C
References[1] Judkowski, V., C. Pinilla, K. Schroder, L. Tucker, N. Sarvetnick, and D. B. Wilson. 2001. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J. Immunol. 166:908–917. PMID:11145667[2] Kim, D.-H., Lee, J.-C., Kim, S., Oh, S.H., Lee, M.-K., Kim, K.-W., Lee, M.-S. (2011) Inhibition of Autoimmune Diabetes by TLR2 Tolerance. J Immunol 187:5211-5220. doi: 10.4049/jimmunol.1001388[3] Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med. 2004 Jun 7;199(11):1467-77. PMID:15184500